In preterm infants receiving paracetamol for patent ductus arteriosus (PDA) treatment, does monitoring serum paracetamol concentrations correlate with reduced risk of hepatotoxicity and improved rates of ductal closure?
Jeevahan, Jevana ; Koritena, Mahmoud ; Ali, Amira ; Noureldein, Mona
Jeevahan, Jevana
Koritena, Mahmoud
Ali, Amira
Noureldein, Mona
Abstract
No abstract available
MIDER Authors
Affiliations
University Hospitals Birmingham NHS Foundation Trust
Date
2025-04-17
Type
Article
Subject
Collections
Citation
Jeevahan J, Koritena M, Ali A, Noureldein M. In preterm infants receiving paracetamol for patent ductus arteriosus (PDA) treatment, does monitoring serum paracetamol concentrations correlate with reduced risk of hepatotoxicity and improved rates of ductal closure? Arch Dis Child. 2025 Apr 17;110(5):407-409. doi: 10.1136/archdischild-2024-328436.
